Inter Miami Takes Equity Stake in Beckham-Founded IM8 Parent

(Design by Grace Hughes, Photos by Megan Briggs/Getty Images, Brennan Asplen/Getty Images)

For the first time, Inter Miami is taking an equity stake in a brand partner.

On Thursday, the South Florida MLS franchise is announcing a multiyear sponsorship deal with health and longevity company Prenetics, with its IM8 subsidiary becoming the exclusive supplements partner of the club. Financial terms were not disclosed, nor was the size of Inter Miami’s ownership interest in Prenetics.

More from Sportico.com

• Sporticast: The WNBA Is Unlike Any Other Major U.S. League
• Las Vegas Group Says It Submitted Bid to Buy MLS' Whitecaps
• KKR Buys Into MLS Next Pro as League Plots Overhaul

The deal continues a robust run of sponsorship additions for Inter Miami, the most valuable team in MLS at $1.45 billion. The club has added new or expanded brand deals with Adidas, Lowe’s, Publix, Modelo, Audi and Ergo Next Insurance to its portfolio since the start of this year alone.

Inter Miami also moved into a new 26,700-seat stadium in April, signing a naming rights deal with Brazilian digital financial services company Nu that Sportico previously reported is one of the largest naming rights deals for a soccer-specific stadium in MLS history.

It’s not a surprise to see IM8 join that group. David Beckham, who co-owns Inter Miami alongside Jorge and Jose Mas, co-founded the supplements brand. After launching in 2024, IM8 eclipsed $100 million in annual recurring revenue in only 11 months. Thus far, the company has supplied over 24 million servings of its products to more than 800,000 customers in 40-plus countries across the globe. IM8 projects its revenue will fall between $180 million and $200 million in 2026.